Current opinion in lipidology

Keyphrases

Publications

volume 35, number 3, 2024

Janneke W C M Mulder, D Meeike Kusters, Jeanine E Roeters van Lennep, Barbara A Hutten
Lipid metabolism during pregnancy: consequences for mother and child. Current opinion in lipidology 35 (3) (2024)
Julius L Katzmann, Ulrich Laufs
PCSK9-directed therapies: an update. Current opinion in lipidology 35 (3) (2024)
Benjamin Bay, Natalie Arnold, Christoph Waldeyer
C-reactive protein, pharmacological treatments and diet: how to target your inflammatory burden. Current opinion in lipidology 35 (3) (2024)
Jing Liu, Henry N Ginsberg, Gissette Reyes-Soffer
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism. Current opinion in lipidology 35 (3) (2024)
Xiangqiang Shao, Robert Steiner, Amy L Peterson
Newborn screening for lipid disorders. Current opinion in lipidology 35 (3) (2024)
Dick C Chan, Gerald F Watts
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses? Current opinion in lipidology 35 (3) (2024)
Benjamin Bay, Natalie Arnold, Christoph Waldeyer
C-reactive protein, pharmacological treatments and diet: how to target your inflammatory burden. Current opinion in lipidology 35 (3) (2024)
Janneke W C M Mulder, D Meeike Kusters, Jeanine E Roeters van Lennep, Barbara A Hutten
Lipid metabolism during pregnancy: consequences for mother and child. Current opinion in lipidology 35 (3) (2024)
Sibbeliene E van den Bosch, Barbara A Hutten, Willemijn E Corpeleijn, D Meeike Kusters
Familial hypercholesterolemia in children and the importance of early treatment. Current opinion in lipidology 35 (3) (2024)
Xiangqiang Shao, Robert Steiner, Amy L Peterson
Newborn screening for lipid disorders. Current opinion in lipidology 35 (3) (2024)
Janneke W C M Mulder, D Meeike Kusters, Jeanine E Roeters van Lennep, Barbara A Hutten
Lipid metabolism during pregnancy: consequences for mother and child. Current opinion in lipidology 35 (3) (2024)
Umesh Tharehalli, Antoine Rimbert
G protein-coupled receptor 146: new insights from genetics and model systems. Current opinion in lipidology 35 (3) (2024)
Jing Liu, Henry N Ginsberg, Gissette Reyes-Soffer
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism. Current opinion in lipidology 35 (3) (2024)
Umesh Tharehalli, Antoine Rimbert
G protein-coupled receptor 146: new insights from genetics and model systems. Current opinion in lipidology 35 (3) (2024)
Janneke W C M Mulder, D Meeike Kusters, Jeanine E Roeters van Lennep, Barbara A Hutten
Lipid metabolism during pregnancy: consequences for mother and child. Current opinion in lipidology 35 (3) (2024)
Sibbeliene E van den Bosch, Barbara A Hutten, Willemijn E Corpeleijn, D Meeike Kusters
Familial hypercholesterolemia in children and the importance of early treatment. Current opinion in lipidology 35 (3) (2024)
Dick C Chan, Gerald F Watts
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses? Current opinion in lipidology 35 (3) (2024)
Julius L Katzmann, Ulrich Laufs
PCSK9-directed therapies: an update. Current opinion in lipidology 35 (3) (2024)
Julius L Katzmann, Ulrich Laufs
PCSK9-directed therapies: an update. Current opinion in lipidology 35 (3) (2024)
Jing Liu, Henry N Ginsberg, Gissette Reyes-Soffer
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism. Current opinion in lipidology 35 (3) (2024)
Paolo Raggi, Maria Laura Becciu, Eliano P Navarese
Remnant cholesterol as a new lipid-lowering target to reduce cardiovascular events. Current opinion in lipidology 35 (3) (2024)
Paolo Raggi, Maria Laura Becciu, Eliano P Navarese
Remnant cholesterol as a new lipid-lowering target to reduce cardiovascular events. Current opinion in lipidology 35 (3) (2024)
Jing Liu, Henry N Ginsberg, Gissette Reyes-Soffer
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism. Current opinion in lipidology 35 (3) (2024)
Xiangqiang Shao, Robert Steiner, Amy L Peterson
Newborn screening for lipid disorders. Current opinion in lipidology 35 (3) (2024)
Sibbeliene E van den Bosch, Barbara A Hutten, Willemijn E Corpeleijn, D Meeike Kusters
Familial hypercholesterolemia in children and the importance of early treatment. Current opinion in lipidology 35 (3) (2024)
Sibbeliene E van den Bosch, Barbara A Hutten, Willemijn E Corpeleijn, D Meeike Kusters
Familial hypercholesterolemia in children and the importance of early treatment. Current opinion in lipidology 35 (3) (2024)
Jing Liu, Henry N Ginsberg, Gissette Reyes-Soffer
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism. Current opinion in lipidology 35 (3) (2024)
Umesh Tharehalli, Antoine Rimbert
G protein-coupled receptor 146: new insights from genetics and model systems. Current opinion in lipidology 35 (3) (2024)
Umesh Tharehalli, Antoine Rimbert
G protein-coupled receptor 146: new insights from genetics and model systems. Current opinion in lipidology 35 (3) (2024)
Sibbeliene E van den Bosch, Barbara A Hutten, Willemijn E Corpeleijn, D Meeike Kusters
Familial hypercholesterolemia in children and the importance of early treatment. Current opinion in lipidology 35 (3) (2024)
Jing Liu, Henry N Ginsberg, Gissette Reyes-Soffer
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism. Current opinion in lipidology 35 (3) (2024)
Janneke W C M Mulder, D Meeike Kusters, Jeanine E Roeters van Lennep, Barbara A Hutten
Lipid metabolism during pregnancy: consequences for mother and child. Current opinion in lipidology 35 (3) (2024)
Janneke W C M Mulder, D Meeike Kusters, Jeanine E Roeters van Lennep, Barbara A Hutten
Lipid metabolism during pregnancy: consequences for mother and child. Current opinion in lipidology 35 (3) (2024)
Sibbeliene E van den Bosch, Barbara A Hutten, Willemijn E Corpeleijn, D Meeike Kusters
Familial hypercholesterolemia in children and the importance of early treatment. Current opinion in lipidology 35 (3) (2024)
Dick C Chan, Gerald F Watts
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses? Current opinion in lipidology 35 (3) (2024)
Paolo Raggi, Maria Laura Becciu, Eliano P Navarese
Remnant cholesterol as a new lipid-lowering target to reduce cardiovascular events. Current opinion in lipidology 35 (3) (2024)
Julius L Katzmann, Ulrich Laufs
PCSK9-directed therapies: an update. Current opinion in lipidology 35 (3) (2024)
Benjamin Bay, Natalie Arnold, Christoph Waldeyer
C-reactive protein, pharmacological treatments and diet: how to target your inflammatory burden. Current opinion in lipidology 35 (3) (2024)
Dick C Chan, Gerald F Watts
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses? Current opinion in lipidology 35 (3) (2024)

volume 35, number 4, 2024

Paul Durrington, Handrean Soran
Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis. Current opinion in lipidology 35 (4) (2024)
Paul Durrington, Handrean Soran
Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis. Current opinion in lipidology 35 (4) (2024)
Christy Foster, Charles A Gagnon, Ambika P Ashraf
Altered lipid metabolism and the development of metabolic-associated fatty liver disease. Current opinion in lipidology 35 (4) (2024)
Bilal Bashir, Maryam Ferdousi, Paul Durrington, Handrean Soran
Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia. Current opinion in lipidology 35 (4) (2024)
Fernando Civeira, César Martín, Ana Cenarro
APOE and familial hypercholesterolemia. Current opinion in lipidology 35 (4) (2024)
Paul Durrington, Handrean Soran
Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis. Current opinion in lipidology 35 (4) (2024)
Tian Chen, Naifeng Liu
How safe are proprotein convertase subtilisinekexin type 9 inhibitors in diabetes? Current opinion in lipidology 35 (4) (2024)
Liam R Brunham
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia? Current opinion in lipidology 35 (4) (2024)
Paulina Elena Stürzebecher, Ulrich Laufs
Proprotein convertase subtilisin/kexin type 9-inhibition across different patient populations. Current opinion in lipidology 35 (4) (2024)
Bilal Bashir, Maryam Ferdousi, Paul Durrington, Handrean Soran
Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia. Current opinion in lipidology 35 (4) (2024)
Bilal Bashir, Maryam Ferdousi, Paul Durrington, Handrean Soran
Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia. Current opinion in lipidology 35 (4) (2024)